{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:18Z","timestamp":1792839018886,"version":"4.5.0"},"reference-count":176,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Epithelial ovarian cancer (EOC) comprises multiple disease states representing a variety of distinct tumors that, irrespective of tissue of origin, genetic aberrations and pathological features, share common patterns of dissemination to the peritoneal cavity. EOC peritoneal dissemination is a stepwise process that includes the formation of malignant outgrowths that detach and establish widespread peritoneal metastases through adhesion to serosal membranes. The cell biology associated with outgrowth formation, detachment, and de novo adhesion is at the nexus of diverse genetic backgrounds that characterize the disease. Development of treatment for metastatic disease will require detailed characterization of cellular processes involved in each step of EOC peritoneal dissemination. This article offers a review of the literature that relates to the current stage of knowledge about distinct steps of EOC peritoneal dissemination, with emphasis on the cell biology aspects of the process.<\/jats:p>","DOI":"10.3390\/cancers11121957","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T10:41:44Z","timestamp":1575628904000},"page":"1957","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Ovarian Cancer Dissemination\u2014A Cell Biologist\u2019s Perspective"],"prefix":"10.3390","volume":"11","author":[{"given":"Sadaf","family":"Farsinejad","sequence":"first","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-0431","authenticated-orcid":false,"given":"Thomas","family":"Cattabiani","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-9002","authenticated-orcid":false,"given":"Taru","family":"Muranen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-8447","authenticated-orcid":false,"given":"Marcin","family":"Iwanicki","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Stevens Institute of Technology, Hoboken, NJ 07030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hirst, J., Crow, J., and Godwin, A. (2018). Ovarian Cancer Genetics: Subtypes and Risk Factors. Ovarian Cancer. Pathog. Treat., 1.","DOI":"10.5772\/intechopen.72705"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62550-3","article-title":"Role of beta-catenin\/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas","volume":"160","author":"Zhai","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2013.107","article-title":"Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles","volume":"27","author":"McConechy","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fonc.2018.00577","article-title":"The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer","volume":"8","author":"Zhou","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1038\/s41467-019-11862-x","article-title":"The molecular origin and taxonomy of mucinous ovarian carcinoma","volume":"10","author":"Cheasley","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000441791","article-title":"Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary","volume":"81","author":"Massad","year":"2016","journal-title":"Gynecol. Obs. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11912-014-0389-x","article-title":"Mucinous tumors of the ovary: Current thoughts on diagnosis and management","volume":"16","author":"Brown","year":"2014","journal-title":"Curr. Oncol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-014-1599-1","article-title":"Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma","volume":"465","author":"Zannoni","year":"2014","journal-title":"Virchows Arch."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.5468\/ogs.2017.60.6.593","article-title":"Skin metastases in ovarian clear cell adenocarcinoma: A case report and a review of the literature","volume":"60","author":"Nam","year":"2017","journal-title":"Obs. Gynecol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network (2011). Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of BRCAness in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/94.13.990","article-title":"Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers","volume":"94","author":"Jazaeri","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/modpathol.2013.237","article-title":"Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency","volume":"27","author":"Reyes","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12253-010-9345-8","article-title":"Molecular characterization of 103 ovarian serous and mucinous tumors","volume":"17","author":"Vereczkey","year":"2011","journal-title":"Pathol. Oncol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1038\/s41598-017-10432-9","article-title":"Mutational heterogeneity in non-serous ovarian cancers","volume":"7","author":"Teer","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T","article-title":"K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases","volume":"79","author":"Cuatrecasas","year":"1997","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1245\/s10434-011-1572-z","article-title":"Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer","volume":"18","author":"Lin","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.18632\/oncotarget.23921","article-title":"The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours","volume":"9","author":"Kajiyama","year":"2018","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1158\/0008-5472.CAN-04-2933","article-title":"Mutation of the PIK3CA gene in ovarian and breast cancer","volume":"64","author":"Campbell","year":"2004","journal-title":"Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gynor.2013.07.008","article-title":"Patterns of spread of clear cell ovarian cancer: Case report and case series","volume":"6","author":"Kumar","year":"2013","journal-title":"Gynecol. Oncol. Case Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: A mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13000-018-0720-1","article-title":"Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: A case report","volume":"13","author":"Kubo","year":"2018","journal-title":"Diagn. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-0-387-98094-2_16","article-title":"Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis","volume":"149","author":"Kenny","year":"2009","journal-title":"Cancer Treat. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1021\/acs.jproteome.6b00548","article-title":"Glycoproteomic Analysis of Malignant Ovarian Cancer Ascites Fluid Identifies Unusual Glycopeptides","volume":"15","author":"Miyamoto","year":"2016","journal-title":"J. Proteom. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","article-title":"Papillary tubal hyperplasia: The putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis","volume":"35","author":"Kurman","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jnci\/djx269","article-title":"Precancerous Lesions of Ovarian Cancer-A US Perspective","volume":"110","author":"Visvanathan","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ng.3573","article-title":"Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer","volume":"48","author":"McPherson","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41698-018-0063-0","article-title":"Tumor evolution and chemoresistance in ovarian cancer","volume":"2","author":"Kim","year":"2018","journal-title":"NPJ Precis. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.11.007","article-title":"Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)","volume":"125","author":"Kolomainen","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2019.00090","article-title":"Spatio-Temporal Regulation of RhoGTPases Signaling by Myosin II","volume":"7","author":"Wu","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4161\/15384101.2014.989127","article-title":"Active contractility at E-cadherin junctions and its implications for cell extrusion in cancer","volume":"14","author":"Wu","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1242\/jcs.057976","article-title":"Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells","volume":"123","author":"Kajita","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ncb1853","article-title":"Characterization of the interface between normal and transformed epithelial cells","volume":"11","author":"Hogan","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-018-07163-4","article-title":"Src-transformed cells hijack mitosis to extrude from the epithelium","volume":"9","author":"Anton","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1800165","DOI":"10.1002\/bies.201800165","article-title":"Cell-Cycle-Dependent Regulation of Cell Adhesions: Adhering to the Schedule: Three papers reveal unexpected properties of adhesion structures as cells progress through the cell cycle","volume":"41","author":"Li","year":"2019","journal-title":"Bioessays"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/PAS.0b013e31825ec07a","article-title":"The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma","volume":"36","author":"Kuhn","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Iwanicki, M.P., Chen, H.Y., Iavarone, C., Zervantonakis, I.K., Muranen, T., Novak, M., Ince, T.A., Drapkin, R., and Brugge, J.S. (2016). Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. JCI Insight, 1.","DOI":"10.1172\/jci.insight.86829"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature10826","article-title":"Outgrowth of single oncogene-expressing cells from suppressive epithelial environments","volume":"482","author":"Leung","year":"2012","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e99144","DOI":"10.15252\/embj.201899144","article-title":"Metastasis inside-out: Dissemination of cancer cell clusters with inverted polarity","volume":"37","author":"Ewald","year":"2018","journal-title":"EMBO J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41556-017-0027-6","article-title":"Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas","volume":"20","author":"Zajac","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","article-title":"Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: A potential role in I. p. metastatic dissemination","volume":"69","author":"Moss","year":"2009","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Kalos","year":"2018","journal-title":"Oncogene"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: A unifying hypothesis","volume":"30","author":"Auersperg","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Doberstein, K.S., Spivak, R., Feng, Y., Stuckelberger, S., Mills, G.B., Devins, K.M., Schwartz, L.E., Iwanicki, M.P., Fogel, M., and Altevogt, P. (2018). Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis. BioRxiv, 270785.","DOI":"10.1101\/270785"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1074\/jbc.M210151200","article-title":"Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1","volume":"278","author":"Olivo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1042\/bj3301107","article-title":"Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G\/H synthase-2 and Egr-1: A critical role for the mitogen-activated protein kinase p38 and for Rho proteins","volume":"330","author":"Reiser","year":"1998","journal-title":"Biochem. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/emboj\/18.2.386","article-title":"PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor","volume":"18","author":"Takeda","year":"1999","journal-title":"EMBO J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ncb2507","article-title":"PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of Galpha12","volume":"14","author":"Gan","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.RES.0000097607.14733.0C","article-title":"G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: Regulation of cell shape and reactive oxygen species production","volume":"93","author":"Niu","year":"2003","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1074\/jbc.M007541200","article-title":"Regulation of Rac and Cdc42 pathways by G(i) during lysophosphatidic acid-induced cell spreading","volume":"276","author":"Ueda","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/s41598-019-41352-5","article-title":"Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6","volume":"9","author":"Chryplewicz","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1242\/jcs.020941","article-title":"FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts","volume":"121","author":"Iwanicki","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cellsig.2006.11.004","article-title":"Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells","volume":"19","author":"Jiang","year":"2007","journal-title":"Cell. Signal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1242\/jcs.107.12.3643","article-title":"Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation","volume":"107","author":"Burridge","year":"1994","journal-title":"J. Cell Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/gyno.2002.6831","article-title":"Lysophosphatidic acid induces focal adhesion assembly through Rho\/Rho-associated kinase pathway in human ovarian cancer cells","volume":"87","author":"Sawada","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","article-title":"Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids","volume":"159","author":"Casey","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/gyno.1998.5262","article-title":"Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion","volume":"72","author":"Carreiras","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00123391","article-title":"Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: A possible step in peritoneal metastasis","volume":"14","author":"Gardner","year":"1996","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/0008-5472.CAN-06-2941","article-title":"The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells","volume":"67","author":"Kulbe","year":"2007","journal-title":"Cancer Res."},{"key":"ref_63","first-page":"566","article-title":"Profiling of cytokines in human epithelial ovarian cancer ascites","volume":"2","author":"Matte","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-alpha and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zong, X., Mitra, S., Mitra, A.K., Matei, D., and Nephew, K.P. (2018). IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells. JCI Insight, 3.","DOI":"10.1172\/jci.insight.122360"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1172\/JCI62229","article-title":"HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts","volume":"122","author":"Ko","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1158\/1078-0432.CCR-10-3314","article-title":"IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer","volume":"17","author":"Anglesio","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9378(91)90582-C","article-title":"Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer","volume":"164","author":"Berek","year":"1991","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/annonc\/4.suppl_4.S71","article-title":"Advanced ovarian cancer","volume":"4","author":"Rustin","year":"1993","journal-title":"Tumour Markers Ann. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"19448","DOI":"10.1016\/S0021-9258(18)41796-6","article-title":"Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras. GTP complex in rat pheochromocytoma PC12 cells","volume":"267","author":"Nakafuku","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1038\/sj.onc.1205387","article-title":"Activation of N-ras and K-ras induced by interleukin-6 in a myeloma cell line: Implications for disease progression and therapeutic response","volume":"21","author":"Rowley","year":"2002","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.CIR.103.4.555","article-title":"Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase\/Akt phosphorylation and Bcl-xL\/caspase-3 interaction","volume":"103","author":"Negoro","year":"2001","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.90381.2008","article-title":"IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K\/Akt-mediated Bax phosphorylation","volume":"297","author":"Kolliputi","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1074\/jbc.M100740200","article-title":"Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl xL","volume":"276","author":"Kovalovich","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1535-7163.MCT-18-0413","article-title":"Combined MEK and BCL-2\/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient-Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness","volume":"18","author":"Iavarone","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref_76","first-page":"560","article-title":"Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis","volume":"118","author":"Popivanova","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_77","first-page":"445","article-title":"An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors","volume":"2","author":"Scott","year":"2003","journal-title":"Mol. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1158\/0008-5472.CAN-05-1936","article-title":"Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2\/microsomal prostaglandin E synthase-1 transgenic mice","volume":"65","author":"Oshima","year":"2005","journal-title":"Cancer Res."},{"key":"ref_79","first-page":"6547","article-title":"Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice","volume":"63","author":"Wheeler","year":"2003","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/sj.onc.1205588","article-title":"Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway","volume":"21","author":"Arnott","year":"2002","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.0604008103","article-title":"TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis","volume":"103","author":"Yang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1242\/jcs.03014","article-title":"NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells","volume":"119","author":"Yan","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1158\/0008-5472.CAN-11-2178","article-title":"A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment","volume":"72","author":"Kulbe","year":"2012","journal-title":"Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1172\/JCI39065","article-title":"The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans","volume":"119","author":"Charles","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1172\/JCI87252","article-title":"Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1158\/0008-5472.CAN-09-1868","article-title":"Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor","volume":"69","author":"Patsialou","year":"2009","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/0008-5472.CAN-04-1853","article-title":"Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1\/epidermal growth factor paracrine loop","volume":"65","author":"Goswami","year":"2005","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0002-9440(10)65406-5","article-title":"CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells","volume":"154","author":"Lessan","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1593\/neo.91272","article-title":"Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: The role of gonadotropins","volume":"12","author":"Tzuman","year":"2010","journal-title":"Neoplasia"},{"key":"ref_91","first-page":"3830","article-title":"Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H","volume":"53","author":"Cannistra","year":"1993","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ccell.2016.06.020","article-title":"Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche","volume":"30","author":"Miranda","year":"2016","journal-title":"Cancer Cell."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/2159-8290.CD-12-0206","article-title":"MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer","volume":"2","author":"Mitra","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1172\/JCI33775","article-title":"The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin","volume":"118","author":"Kenny","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1084\/jem.20181170","article-title":"Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum","volume":"216","author":"Lee","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/0008-5472.CAN-15-1382","article-title":"It\u2019s totally Tubular Riding The New Wave of Ovarian Cancer Research","volume":"76","author":"Perets","year":"2016","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: A descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.devcel.2018.01.009","article-title":"Cell Extrusion: A Stress-Responsive Force for Good or Evil in Epithelial Homeostasis","volume":"44","author":"Ohsawa","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ceb.2018.04.007","article-title":"The forces and fates of extruding cells","volume":"54","author":"Fadul","year":"2018","journal-title":"Curr. Opin. Cell. Biol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-cellbio-100616-060748","article-title":"Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease","volume":"34","author":"Gudipaty","year":"2018","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11596-019-2048-9","article-title":"A Potential Model for Detecting Crowding-induced Epithelial Cell and Cancer Cell Extrusion","volume":"39","author":"Han","year":"2019","journal-title":"Curr. Med. Sci."},{"key":"ref_107","first-page":"144","article-title":"Root fracture in cervical third of a tooth with an open apex-with healing","volume":"6","author":"Hagen","year":"1991","journal-title":"Tandlaegernes Nye Tidsskr."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00048965","article-title":"Cell detachment and metastasis","volume":"2","author":"Weiss","year":"1983","journal-title":"Cancer Metastasis Rev."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Tanimura, N., and Fujita, Y. (2019). Epithelial defense against cancer (EDAC). Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2019.05.011"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Tamori, Y., Suzuki, E., and Deng, W.M. (2016). Epithelial Tumors Originate in Tumor Hotspots, a Tissue-Intrinsic Microenvironment. PLoS. Biol., 14.","DOI":"10.1371\/journal.pbio.1002537"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/PAS.0b013e318282da7f","article-title":"Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: A novel metastatic route in early pelvic carcinogenesis","volume":"37","author":"Bijron","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"425.e1","DOI":"10.1016\/j.ajog.2017.06.004","article-title":"Persistence of fimbrial tissue on the ovarian surface after salpingectomy","volume":"217","author":"Gan","year":"2017","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_115","first-page":"S118","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"119","author":"Berek","year":"2012","journal-title":"Int. J. Gynaecol. Obs."},{"key":"ref_116","first-page":"677","article-title":"Clinical importance of enzyme investigations of ascitic fluid caused by malignant ovarian neoplasms","volume":"10","author":"Santoni","year":"1958","journal-title":"Minerva Ginecol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI114784","article-title":"Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells","volume":"86","author":"Mills","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_118","first-page":"1066","article-title":"A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization, and mechanism of action","volume":"48","author":"Mills","year":"1988","journal-title":"Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/jnci\/93.10.762","article-title":"Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells","volume":"93","author":"Hu","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ijc.22006","article-title":"Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas","volume":"119","author":"Adachi","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: New avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The Unique Molecular and Cellular Microenvironment of Ovarian Cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.280.8.719","article-title":"Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers","volume":"280","author":"Xu","year":"1998","journal-title":"JAMA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.lfs.2006.12.041","article-title":"Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels of bioactive lysophospholipase D activity","volume":"80","author":"Tokumura","year":"2007","journal-title":"Life Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0955-0674(97)80059-2","article-title":"Lysophosphatidic acid: G-protein signalling and cellular responses","volume":"9","author":"Moolenaar","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.onc.1204187","article-title":"Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists","volume":"20","author":"Kranenburg","year":"2001","journal-title":"Oncogene"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1091\/mbc.10.6.1851","article-title":"Activation of Rho A by lysophosphatidic acid and Galpha12\/13 subunits in neuronal cells: Induction of neurite retraction","volume":"10","author":"Kranenburg","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1073\/pnas.90.4.1257","article-title":"Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts","volume":"90","author":"Hordijk","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","first-page":"3704","article-title":"Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells","volume":"5","author":"Pustilnik","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","article-title":"Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer","volume":"905","author":"Fang","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_133","first-page":"2482","article-title":"Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2","volume":"6","author":"Eder","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.canlet.2018.11.023","article-title":"Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts","volume":"442","author":"Radhakrishnan","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_135","first-page":"194","article-title":"Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions","volume":"55","author":"Allen","year":"1987","journal-title":"Exp. Cell. Biol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3835(94)03625-S","article-title":"Increased levels of laminin in ascitic fluid of patients with ovarian cancer","volume":"88","author":"Byers","year":"1995","journal-title":"Cancer Lett."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hh2401.101084","article-title":"Integrin and growth factor receptor crosstalk","volume":"89","author":"Eliceiri","year":"2001","journal-title":"Circ. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-2-23","article-title":"Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC)","volume":"2","author":"Freedman","year":"2004","journal-title":"J. Transl. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1006\/cyto.1995.0073","article-title":"IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells","volume":"7","author":"Offner","year":"1995","journal-title":"Cytokine"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1995.71","article-title":"Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer","volume":"71","author":"Scambia","year":"1995","journal-title":"Br. J. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.2910570305","article-title":"Interleukin-6 serum levels in patients with gynecological tumors","volume":"57","author":"Scambia","year":"1994","journal-title":"Int. J. Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"23013","DOI":"10.1074\/jbc.274.33.23013","article-title":"Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase\/Akt and signal transducers and activators of transcription 3 pathways","volume":"274","author":"Chen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood.V89.1.227","article-title":"Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells","volume":"89","author":"Chauhan","year":"1997","journal-title":"Blood"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1093\/carcin\/22.12.1947","article-title":"IL-6 inhibits apoptosis and retains oxidative DNA lesions in human gastric cancer AGS cells through up-regulation of anti-apoptotic gene mcl-1","volume":"22","author":"Lin","year":"2001","journal-title":"Carcinogenesis"},{"key":"ref_147","first-page":"647","article-title":"Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone","volume":"6","author":"Lotem","year":"1995","journal-title":"Cell Growth Differ."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/978-0-387-69080-3_56","article-title":"Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma","volume":"617","author":"Cavarretta","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-08-2419","article-title":"Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: Implications for microenvironment influence on tumor survival and proliferation","volume":"69","author":"Shain","year":"2009","journal-title":"Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L","article-title":"Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer","volume":"72","author":"Moradi","year":"1993","journal-title":"Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0015-0282(98)00400-2","article-title":"Whole explants of peritoneum and endometrium: A novel model of the early endometriosis lesion","volume":"71","author":"Witz","year":"1999","journal-title":"Fertil. Steril."},{"key":"ref_153","first-page":"1236","article-title":"Morphogenesis of peritoneal metastasis in human gastric cancer","volume":"41","author":"Kiyasu","year":"1981","journal-title":"Cancer Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/2159-8290.CD-11-0117","article-title":"The first line of intra-abdominal metastatic attack: Breaching the mesothelial cell layer","volume":"1","author":"Kenny","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1158\/1541-7786.MCR-13-0489","article-title":"P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions","volume":"12","author":"Usui","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","article-title":"Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers","volume":"93","author":"Burleson","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1158\/0008-5472.CAN-08-2678","article-title":"Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis","volume":"69","author":"Atkins","year":"2009","journal-title":"Cancer Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Dean, M., Jin, V., Bergsten, T.M., Austin, J.R., Lantvit, D.D., Russo, A., and Burdette, J.E. (2019). Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary. Cancers, 11.","DOI":"10.3390\/cancers11060884"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41388-017-0043-9","article-title":"TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis","volume":"37","author":"Grither","year":"2018","journal-title":"Oncogene"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"25115","DOI":"10.18632\/oncotarget.25344","article-title":"ADH1B promotes mesothelial clearance and ovarian cancer infiltration","volume":"9","author":"Gharpure","year":"2018","journal-title":"Oncotarget"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Nan, P., Walsh, D.M., Landman, K.A., and Hughes, B.D. (2018). Distinguishing cell shoving mechanisms. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193975"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1038\/onc.2017.171","article-title":"Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis","volume":"36","author":"Klymenko","year":"2017","journal-title":"Oncogene"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/oncsis.2016.64","article-title":"SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance","volume":"5","author":"Sheets","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI69815","article-title":"Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance","volume":"124","author":"Davidowitz","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-derived miRNAs and ovarian carcinoma progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"20246","DOI":"10.1074\/jbc.271.34.20246","article-title":"Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)","volume":"271","author":"Amano","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Kwon, Y., Cukierman, E., and Godwin, A.K. (2011). Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration\/invasion. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018872"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1038\/s41598-019-44123-4","article-title":"Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells","volume":"9","author":"Pakula","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0014-4827(85)90197-1","article-title":"Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion","volume":"160","author":"Niedbala","year":"1985","journal-title":"Exp. Cell. Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/fon-2016-0431","article-title":"Malignant bowel obstruction in advanced ovarian cancer","volume":"13","author":"Dean","year":"2017","journal-title":"Future Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/CMAR.S29297","article-title":"Malignant bowel obstruction in advanced cancer patients: Epidemiology, management, and factors influencing spontaneous resolution","volume":"4","author":"Tuca","year":"2012","journal-title":"Cancer Manag. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjsurg.2011.07.013","article-title":"Outcomes of small bowel obstruction in patients with previous gynecologic malignancies","volume":"203","author":"Mirensky","year":"2012","journal-title":"Am. J. Surg."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1957\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:40:49Z","timestamp":1760190049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/12\/1957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":176,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["cancers11121957"],"URL":"https:\/\/doi.org\/10.3390\/cancers11121957","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,6]]}}}